68546-229 : Azilect 1 mg Oral Tablet


NDC: 68546-229
Labeler: Teva Neuroscience, Inc.
Product Type: Human Prescription Drug
Drug Name:  Azilect
Dosage Form: Oral Tablet
Application #: NDA021641
Rev. Date: 


Appearance:


Markings: GIL;1
Shapes:  Round
Colors:  White
Size (mm): 8
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

GIL 1: (68546-229) Azilect 1 mg Oral Tablet by Teva Neuroscience, Inc.
The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.

NDC Package Codes:

  • 68546-229-27: 1 BLISTER PACK IN 1 CARTON (68546‑229‑27) > 7 TABLET IN 1 BLISTER PACK
  • 68546-229-56: 30 TABLET IN 1 BOTTLE, PLASTIC (68546‑229‑56)

Active Ingredients:

  • Rasagiline Mesylate

Dosage Strength:

  • 1 mg

Inactive Ingredients:

  • Mannitol
  • Starch, Corn
  • Silicon Dioxide
  • Stearic Acid
  • Talc

Pharmaceutical Classes:

  • Monoamine Oxidase Inhibitor [EPC]
  • Monoamine Oxidase Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 68546-142 Azilect 0.5 mg Oral Tablet by Teva Neuroscience, Inc.
  • 43353-015 Azilect 1 mg Oral Tablet by Aphena Pharma Solutions - Tennessee, LLC
  • 54868-6206 Azilect 1 mg Oral Tablet by Physicians Total Care, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 68546-229 QR Code

< Prev: 68546-182Next: 68546-317 >

Related Discussions:

rasagiline
Anyone taking this anything to say about it? I've started on it today !...
azilect
for parkinsons...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.